查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1565015

癌症資訊系統的全球市場

Oncology Information Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球癌症資訊系統市場將達到 64 億美元

全球癌症資訊系統市場預計 2023 年為 42 億美元，預計到 2030 年將達到 64 億美元，2023 年至 2030 年複合年成長率為 6.1%。 「軟體組件」是本報告分析的細分市場之一，預計複合年成長率為 6.7%，到分析期結束時將達到 55 億美元。分析期間內，服務組件產業的複合年成長率預計為 3.2%。

美國市場預計將成長12億美元，中國複合年成長率為5.7%

到 2023 年，美國癌症資訊系統市場預計將達到 12 億美元。中國作為世界第二大經濟體，預計到 2030 年市場規模將達到 9.947 億美元，2023-2030 年分析期間複合年成長率為 5.7%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 5.7% 和 4.7%。在歐洲，德國的複合年成長率預計為 4.8%。

全球癌症資訊系統市場 - 主要趨勢和促進因素總結

什麼是癌症資訊系統？

癌症資訊系統（OIS）是一個專業的數位平台，旨在管理全面的癌症護理。這些系統將患者資料管理、治療計劃、臨床工作流程和決策支援工具等各種功能整合到一個解決方案中。透過簡化患者記錄文件、追蹤治療通訊協定以及改善多學科團隊之間的溝通，OIS 在提高癌症護理的品質和效率方面發揮關鍵作用。這些系統被醫院、癌症治療中心和研究機構廣泛採用，以促進精準醫療、監測患者結果並確保遵守不斷發展的治療指南。隨著全球癌症發生率的增加，癌症資訊系統正成為對抗這種複雜疾病的重要工具。

科技進步如何形塑癌症資訊系統？

技術進步是不斷發展的癌症資訊系統的核心，推動治療計劃、資料分析和患者照護的顯著改進。最根本的創新之一是人工智慧（AI）和機器學習演算法的整合，它可以分析大量患者資料並預測治療結果，幫助臨床醫生製定個人化治療計劃。此外，OIS 平台具有高度互通性，可實現不同醫療保健系統、電子健康記錄(EHR) 和醫學影像技術之間的無縫資料交換。雲端基礎的癌症資訊系統也越來越受歡迎，提供增強的可存取性、擴充性和資料安全性。隨著遠端醫療變得越來越普遍，OIS 平台正在整合遠端患者監護工具，使腫瘤學家能夠即時追蹤患者的進展並相應地調整治療通訊協定。

為什麼癌症資訊系統在醫療保健領域的採用越來越多？

全球癌症發生率不斷上升，增加了對高效、全面的癌症護理管理系統的需求，推動了 OIS 的採用。此類系統在複雜的多學科癌症治療中特別有用，在這種治療中，不同專家之間的合作非常重要。隨著醫療保健行業轉向基於價值的護理，癌症資訊系統可幫助醫療保健提供者追蹤治療結果、患者依從性和整體醫療保健成本，從而為癌症治療做出更具成本效益、以結果為導向的貢獻。此外，人們越來越重視精準腫瘤學，它可以根據個人的遺傳特徵提供量身定做的治療方法，並依賴 OIS 來管理個人化治療計劃所需的大量遺傳和臨床資料。將OIS與放射線治療、化療系統結合將進一步提高治療的精準度和效率。

推動癌症資訊系統市場成長的因素有哪些？

癌症資訊系統市場的成長受到多種因素的推動，包括全球癌症負擔的增加以及協作癌症護理管理的需求不斷成長。人工智慧驅動的治療計劃、雲端基礎平台和遠端監控工具等技術進步極大地提高了 OIS 的功能和可近性，使其成為現代癌症護理的重要組成部分。向精準醫療和個人化癌症治療的轉變也是一個關鍵促進因素，OIS 對於管理與基因組學和個人化治療計劃相關的複雜資料集集至關重要。此外，醫療保健提供者擴大採用 OIS 來滿足文件、治療通訊協定和病人安全的監管要求。隨著癌症綜合治療需求的持續上升，OIS平台正成為癌症治療不可或缺的一部分，推動該市場持續成長。

受訪企業範例（43家知名企業）

  • Accuray, Inc.
  • Cerner Corporation
  • Elekta AB
  • Epic Systems Corporation
  • Flatiron Health, Inc.
  • Koninklijke Philips NV
  • McKesson Corporation
  • RAYSEARCH Laboratories AB
  • Varian Medical Systems, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP13703

Global Oncology Information Systems Market to Reach US$6.4 Billion by 2030

The global market for Oncology Information Systems estimated at US$4.2 Billion in the year 2023, is expected to reach US$6.4 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Software Component, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$5.5 Billion by the end of the analysis period. Growth in the Services Component segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 5.7% CAGR

The Oncology Information Systems market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$994.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Oncology Information Systems Market – Key Trends & Drivers Summarized

What Are Oncology Information Systems and Why Are They Crucial?

Oncology information systems (OIS) are specialized digital platforms designed to manage comprehensive cancer care. These systems integrate various functions, including patient data management, treatment planning, clinical workflows, and decision support tools, into a single solution. By streamlining the documentation of patient records, tracking treatment protocols, and improving communication between multidisciplinary teams, OIS play a vital role in enhancing the quality and efficiency of oncology care. These systems are widely adopted by hospitals, cancer treatment centers, and research institutions, where they facilitate precision medicine, monitor patient outcomes, and ensure compliance with evolving treatment guidelines. With the increasing incidence of cancer globally, oncology information systems are becoming an essential tool in the fight against this complex disease.

How Are Technological Advancements Shaping Oncology Information Systems?

Technological advancements are at the core of the evolving oncology information systems landscape, driving significant improvements in treatment planning, data analytics, and patient care. One of the most transformative innovations has been the integration of artificial intelligence (AI) and machine learning algorithms, which assist clinicians in developing personalized treatment plans by analyzing vast amounts of patient data and predicting outcomes. Additionally, OIS platforms are becoming more interoperable, allowing seamless data exchange between different healthcare systems, electronic health records (EHR), and medical imaging technologies. Cloud-based oncology information systems are also gaining traction, offering enhanced accessibility, scalability, and data security. As telemedicine becomes more prevalent, OIS platforms are integrating remote patient monitoring tools, enabling oncologists to track patient progress in real time and adjust treatment protocols accordingly.

Why Is the Adoption of Oncology Information Systems Increasing in Healthcare?

The rising incidence of cancer worldwide has increased the demand for efficient and comprehensive cancer care management systems, driving the adoption of OIS. These systems are particularly valuable in complex, multidisciplinary cancer treatments, where coordination between various specialists is critical. As the healthcare industry shifts towards value-based care, oncology information systems help providers track treatment outcomes, patient adherence, and overall healthcare costs, contributing to more cost-effective and outcome-driven cancer care. Moreover, the growing emphasis on precision oncology, which tailors treatments to the individual’s genetic profile, relies heavily on OIS to manage the vast amounts of genetic and clinical data required for personalized treatment plans. The integration of OIS with radiation therapy and chemotherapy systems further enhances treatment accuracy and efficiency.

What Factors Are Driving Growth in the Oncology Information Systems Market?

The growth in the oncology information systems market is driven by several factors, including the rising global cancer burden and the increasing need for coordinated cancer care management. Technological advancements, such as AI-driven treatment planning, cloud-based platforms, and remote monitoring tools, are significantly improving the functionality and accessibility of OIS, making them essential in modern oncology practices. The shift toward precision medicine and personalized cancer therapies is another key driver, as OIS are indispensable for managing the complex data sets associated with genomics and individualized treatment plans. Additionally, healthcare providers are increasingly adopting OIS to meet regulatory requirements for documentation, treatment protocols, and patient safety. As the demand for comprehensive cancer care continues to grow, OIS platforms are becoming a vital component of cancer treatment, driving sustained growth in this market.

Select Competitors (Total 43 Featured) -

  • Accuray, Inc.
  • Cerner Corporation
  • Elekta AB
  • Epic Systems Corporation
  • Flatiron Health, Inc.
  • Koninklijke Philips NV
  • McKesson Corporation
  • RAYSEARCH Laboratories AB
  • Varian Medical Systems, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Oncology Information Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Focus on Personalized Cancer Treatment Drives Demand for Advanced Oncology Information Systems (OIS)
    • Increased Adoption of Electronic Health Records (EHR) Integration Expands Addressable Market for OIS Solutions
    • Rising Cancer Incidence Globally Spurs Growth in Oncology Information Systems Deployment Across Healthcare Providers
    • Advancements in AI-Driven Decision Support Systems Propel Growth of Oncology Information Systems for Treatment Planning
    • Value-Based Care Models Strengthen the Business Case for Comprehensive Oncology Information Systems
    • Increased Focus on Precision Medicine Accelerates Demand for Data-Driven Oncology Information Systems
    • Growing Adoption of Cloud-Based Oncology Information Systems Enhances Scalability and Access
    • Rising Need for Multidisciplinary Care Coordination Drives Demand for Integrated Oncology Information Systems
    • Advances in Genomic Data Integration in OIS Platforms Propel Growth in Molecular Oncology Diagnostics
    • Growing Emphasis on Patient-Centric Care Models Expands the Addressable Market for Oncology Information Systems
    • Increasing Utilization of Telemedicine in Cancer Care Spurs Growth in Cloud-Enabled Oncology Information Systems
    • Rising Need for Advanced Reporting and Analytics in Oncology Research and Clinical Trials Generates Demand for OIS Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Oncology Information Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Oncology Information Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Oncology Information Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Oncology Information Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Medical Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Medical Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Medical Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Radiation Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Surgical Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Surgical Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Surgical Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals & Oncology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals & Oncology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospitals & Oncology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Oncology Information Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Oncology Information Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of World 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION